ORGANIZATION AND OPERATIONS (Details) - USD ($) |
12 Months Ended | |||
---|---|---|---|---|
Jan. 12, 2022 |
Mar. 08, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Proceeds from issuance of equity securities | $ 1,987,376 | $ 27,287,638 | ||
Purchase in-process research and development technology | (1,500,000) | 0 | ||
Issuance of equity securities, net | $ 23,000,000.0 | $ 487,900 | $ 27,287,638 | |
Common Stock | ||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Issuance of equity securities, net (in shares) | 40,000 | 672,269 | 40,000 | 802,182 |
Issuance of equity securities, net | $ 4 | $ 81 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of cash inflow from the issuance of equity classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|